Instalab
logoInstalab

Phenylacetic Acid

Urine Test
An exploratory clue to protein breakdown by your body and gut bacteria.
4.9 (3,298 reviews)
Tested by Genova Diagnostics
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Self-collect at home
Kit shipped directly to you
Get results
Explained with clear next steps, no medical jargon

Should you take a Phenylacetic Acid test?

This test is most useful if any of these apply to you.

Interested in Exploratory Metabolic Testing
Explore a product of protein breakdown while recognizing that testing hasn't been shown to improve preventive care.
Being Evaluated for High Phenylalanine
A urine acid pattern may support a metabolic workup, while blood phenylalanine remains the established measure.
Exploring Persistent Gut Symptoms
This provides an exploratory metabolic clue, but it can't diagnose a bacterial imbalance or select a gut treatment.

About Phenylacetic Acid

Phenylalanine is one of the building blocks of protein. Your body uses it to make proteins and usually converts excess amounts into tyrosine. Some is broken down through other routes that produce phenylacetic acid, or PAA. Gut bacteria also make PAA from phenylalanine that reaches the colon.

Free PAA in urine is an exploratory marker of this chemistry. Its association with phenylketonuria is well documented, but its usefulness for assessing gut health, choosing a diet, or predicting future disease hasn't been established. There is no validated prevention target, and a personal trend doesn't by itself make the result clinically useful.

Where It Comes From

PAA can come from both human and bacterial metabolism. It also forms when your body breaks down phenylethylamine, which participates in nervous system signaling. Small human feeding and drug studies found that urinary PAA mainly reflected phenylalanine metabolism and was a poor measure of phenylethylamine activity in the brain.

Your liver and kidneys attach glutamine to much of the PAA produced. The resulting compound is phenylacetylglutamine, usually shortened to PAGln, and it is a major form in which this pathway's products leave in urine. This test measures free PAA. Its level depends on production, conversion into other compounds, kidney handling, and urine concentration, so it doesn't directly measure how much protein your gut bacteria ferment.

Phenylketonuria

Phenylketonuria, or PKU, usually results from an inherited deficiency of the enzyme that converts phenylalanine into tyrosine. Phenylalanine accumulates and more enters routes that produce phenylacetic, phenyllactic, and phenylpyruvic acids. A classic study directly measured free urinary PAA and found large amounts in untreated PKU. Healthy infants and children with milder high blood phenylalanine generally excreted much less.

A more recent study compared 51 people with early-treated PKU with 51 controls and also found higher urinary PAA. It used a different technique to profile urine, so its numerical results aren't directly comparable with routine organic acid testing. Another small study found that urinary PAGln correlated with blood phenylalanine, but PAGln is a different molecule. Neither study established free urinary PAA as a substitute for blood phenylalanine monitoring.

Blood phenylalanine is the established measurement for newborn screening and treatment monitoring. A urine acid pattern can support a metabolic investigation, but a low or unremarkable PAA result doesn't exclude PKU or establish that it is well controlled.

Mood and Depression

Some small studies in the 1980s found lower urinary PAA in people with depression. Part of this research measured total urinary phenylacetate, including PAA released from attached compounds during sample processing. That is a different measurement from free PAA in this test.

The findings were inconsistent. One study found no difference between people with unipolar depression and controls, and its feeding and drug experiments challenged the idea that urinary PAA reflects brain phenylethylamine. Free urinary PAA hasn't been validated for diagnosing depression or selecting an antidepressant.

Heart Risk and Phenylacetylglutamine

The heart research concerns PAGln in blood. A study involving more than 5,000 people linked higher plasma PAGln with cardiovascular disease and subsequent adverse events. Platelets are the blood components that help form clots. Experiments with human platelets found increased responsiveness to clotting signals, and animal experiments supported a role in clot formation.

Who Was StudiedWhat Was ComparedWhat They Found
631 people with a major heart attack and disease in several coronary arteriesPlasma PAGln above versus below the group's middle valueThe higher group had about 2.8 times the rate of a combined outcome of death, heart attack, stroke, or heart failure after adjustment for other risk factors.
73 people included in the follow-up analysis of a study of heart failure caused by coronary diseaseHigher versus lower serum PAGln groups of nearly equal sizeOver about nine months, the higher group had about 3.5 times the rate of cardiovascular death or heart failure hospitalization after adjustment for hemoglobin and a blood marker of heart strain. The small study produced an imprecise estimate.

These were observational associations involving a different molecule in a different specimen. They don't establish a cardiovascular risk estimate for free urinary PAA, or show that lowering this urine result prevents heart disease.

Gut Inflammation

A study of 262 people found higher serum PAGln in those with Crohn's disease. Crohn's disease causes inflammation in the digestive tract. Bacterial experiments supported a link to microbial phenylalanine breakdown. The mouse experiments used phenylacetylglycine, a related compound that predominates in rodents, and found worse chemically induced colitis. Those findings don't establish that free urinary PAA diagnoses bowel inflammation or identifies a treatment for it.

Understanding a High or Low Result

An unusual result can have several explanations. A pattern involving several phenylalanine-related acids may raise suspicion of altered phenylalanine metabolism. An isolated PAA value cannot distinguish increased bacterial production from changes in your body's processing or excretion. A low result doesn't establish low protein intake, a shortage of a brain chemical, or a healthy microbiome.

When Results Can Be Misleading

  • Different measurements: free urinary PAA, total urinary phenylacetate, and PAGln are not interchangeable. A spot urine result adjusted for creatinine also cannot be compared directly with the amount excreted over a full day.
  • Recent exercise: a pilot study in 20 healthy men found an average 77% increase in 24-hour total urinary PAA after aerobic exercise. It used an assay that included conjugated forms, so that percentage cannot be applied to this free PAA test. The study didn't establish how long the effect lasted beyond the collection period.
  • Diet: a small before-and-after study in 14 volunteers found an increase in a urinary PAA signal during lemon intake. This doesn't show that the change was beneficial or harmful, and it cannot establish a general rule about protein or plant foods.
  • Ammonia-lowering medicines: sodium phenylbutyrate and glycerol phenylbutyrate are converted into PAA. Ornithine phenylacetate supplies PAA and has been studied as an investigational treatment for liver-related confusion. These exposures must be considered before attributing a result to diet or gut bacteria.
  • Urine concentration and creatinine: creatinine adjustment helps account for dilution, but differences in creatinine excretion can still affect the reported ratio. Many urine organic acid patterns also change with age, especially in children.
  • Kidney disease: impaired kidney function can alter the handling of this pathway's products. Drug studies found slower clearance of PAGln, but that finding doesn't specify the direction or size of a change in free urinary PAA.

What Moves This Biomarker

Evidence-backed interventions that affect your Phenylacetic Acid level

↓ Decrease
A prescribed low-phenylalanine diet for phenylketonuria
In a small clinical study of children with PKU, free urinary PAA and related acids were much lower on a low-phenylalanine diet than on an unrestricted diet. Dietary treatment limits the phenylalanine buildup that can harm the brain.
DietStrong Evidence

Frequently Asked Questions

References

19 studies
  1. Silvana K. Rampini, J. a. Völlmin, Hans Rudolf Bosshard, Melanie L. Muller, H.-Ch. CurtiusPediatric Research1974
  2. Claire Cannet, Allan Bayat, Georg Frauendienst-egger, Peter Freisinger, Manfred Spraul, Nastassja Himmelreich, Musa Kockaya, Kirsten Ahring, Markus Godejohann, Anita Macdonald, Friedrich K. TrefzMolecules2023
  3. Fernando Andrade, Ainara Cano, María Unceta Suárez, Arantza Arza, Ana Vinuesa, Leticia Ceberio, Nuria López-osle, Gorka De Frutos, Raquel López-oceja, Elena Aznal, Domingo González-lamuño, Javier De Las HerasJournal of Clinical Medicine2021
  4. Wendy E. Smith, Susan a. Berry, Kaitlyn Bloom, Christine Brown, Barbara K. Burton, Olivia M. Demarest, Gabrielle P. Jenkins, Jennifer Malinowski, Kim L. Mcbride, H. Joel Mroczkowski, Curt Scharfe, Jerry Vockley, ACMG Board of DirectorsGenetics in Medicine2025
  5. Hector C. Sabelli, Jan a. Fawcett, Fabian Gusovsky, J. I. Javaid, J. Edwards, Helen JeffriessScience1983

Phenylacetic Acid Testing Options

$405

See the chemical trail your metabolism leaves behind, and explore where your energy, gut, and nutrient pathways may be under strain.

Includes 49 biomarkers:
Phenylacetic Acid3-Indoleacetic AcidDHPPA3-Hydroxyphenylacetic Acid4-Hydroxyphenylacetic Acid
$509

A comprehensive at-home nutritional and metabolic assessment that analyzes key biomarkers to reveal functional nutrient needs and imbalances.

90 biomarkers
FSA/HSA eligible
No Rx needed
HIPAA compliant